Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1079 (LINC01079) is a member of the lincRNA family, transcribed from intergenic regions and lacking protein-coding potential. LincRNAs—including LINC01079—are generally implicated in the regulation of gene expression, chromatin architecture, and may act as scaffolds for protein complexes[5][3]. Although some lincRNAs are well-characterized as biomarkers or therapeutic targets in cancers, limited published data currently describe the specific functions or disease associations of LINC01079. Further research is needed to clarify its molecular interactions, biomarker potential, and therapeutic relevance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1079 (LINC01079).